BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27714554)

  • 1. Intrinsic functional connectivity alterations in cognitively intact elderly APOE ε4 carriers measured by eigenvector centrality mapping are related to cognition and CSF biomarkers: a preliminary study.
    Luo X; Qiu T; Jia Y; Huang P; Xu X; Yu X; Shen Z; Jiaerken Y; Guan X; Zhou J; Zhang M;
    Brain Imaging Behav; 2017 Oct; 11(5):1290-1301. PubMed ID: 27714554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered effective connectivity anchored in the posterior cingulate cortex and the medial prefrontal cortex in cognitively intact elderly APOE ε4 carriers: a preliminary study.
    Luo X; Li K; Jia YL; Zeng Q; Jiaerken Y; Qiu T; Huang P; Xu X; Shen Z; Guan X; Zhou J; Wang C; Xu JJ; Zhang M;
    Brain Imaging Behav; 2019 Feb; 13(1):270-282. PubMed ID: 29549664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional brain network centrality is related to APOE genotype in cognitively normal elderly.
    Wink AM; Tijms BM; Ten Kate M; Raspor E; de Munck JC; Altena E; Ecay-Torres M; Clerigue M; Estanga A; Garcia-Sebastian M; Izagirre A; Martinez-Lage Alvarez P; Villanua J; Barkhof F; Sanz-Arigita E
    Brain Behav; 2018 Sep; 8(9):e01080. PubMed ID: 30136422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation.
    Skouras S; Torner J; Andersson P; Koush Y; Falcon C; Minguillon C; Fauria K; Alpiste F; Blenow K; Zetterberg H; Gispert JD; Molinuevo JL;
    Brain; 2020 Mar; 143(3):976-992. PubMed ID: 32091109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
    Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
    BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ4 Carriers: A Preliminary Study.
    Luo X; Qiu T; Xu X; Huang P; Gu Q; Shen Z; Yu X; Jia Y; Guan X; Song R; Zhang M;
    J Alzheimers Dis; 2016; 50(4):1137-48. PubMed ID: 26836191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau.
    Butt OH; Meeker KL; Wisch JK; Schindler SE; Fagan AM; Benzinger TLS; Cruchaga C; Holtzman DM; Morris JC; Ances BM
    Alzheimers Dement; 2022 Jan; 18(1):116-126. PubMed ID: 34002449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
    Voevodskaya O; Sundgren PC; Strandberg O; Zetterberg H; Minthon L; Blennow K; Wahlund LO; Westman E; Hansson O;
    Neurology; 2016 May; 86(19):1754-61. PubMed ID: 27164711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern.
    Risacher SL; Kim S; Nho K; Foroud T; Shen L; Petersen RC; Jack CR; Beckett LA; Aisen PS; Koeppe RA; Jagust WJ; Shaw LM; Trojanowski JQ; Weiner MW; Saykin AJ;
    Alzheimers Dement; 2015 Dec; 11(12):1417-1429. PubMed ID: 25960448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
    J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional gradients of the medial parietal cortex in a healthy cohort with family history of sporadic Alzheimer's disease.
    Veréb D; Mijalkov M; Chang YW; Canal-Garcia A; Gomez-Ruis E; Maass A; Villeneuve S; Volpe G; Pereira JB
    Alzheimers Res Ther; 2023 Apr; 15(1):82. PubMed ID: 37076873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF Aβ
    Lim YY; Yassi N; Bransby L; Ayton S; Buckley RF; Eratne D; Velakoulis D; Li QX; Fowler C; Masters CL; Maruff P
    Neurobiol Aging; 2023 Sep; 129():209-218. PubMed ID: 37399739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between APOE genotype, CSF Tau and cognition across the Alzheimer's disease spectrum, moderation and mediation role of insula network connectivity.
    Zhu Y; Wu Y; Lv X; Wu J; Shen C; Tang Q; Wang G;
    CNS Neurosci Ther; 2024 Jan; 30(1):e14401. PubMed ID: 37577852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in CSF biomarkers vary by Alzheimer disease stage and
    Babapour Mofrad R; Tijms BM; Scheltens P; Barkhof F; van der Flier WM; Sikkes SAM; Teunissen CE
    Neurology; 2020 Oct; 95(17):e2378-e2388. PubMed ID: 32788242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly.
    Koivumäki M; Ekblad L; Lantero-Rodriguez J; Ashton NJ; Karikari TK; Helin S; Parkkola R; Lötjönen J; Zetterberg H; Blennow K; Rinne JO; Snellman A
    Alzheimers Res Ther; 2024 May; 16(1):112. PubMed ID: 38762725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
    Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
    Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.